Affiliations 

  • 1 Bioprocess Technology, School of Industrial Technology, Universiti Sains Malaysia, Gelugor, Penang, Malaysia
  • 2 Faculty of Medicine, AIMIST University, Bedong, Kedah, Malaysia
  • 3 Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Gelugor, Penang, Malaysia
  • 4 Department of Obstetrics and Gynecology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia
  • 5 Faculty of Medicine and Health Sciences (FMHS), Universiti Malaysia Sarawak (UNIMAS), Kota Samarahan, Sarawak, Malaysia
  • 6 Obstetrics and Gynecology, Sunway Medical Centre Penang, Gelugor, Penang, Malaysia
Int J Gynaecol Obstet, 2024 Nov 09.
PMID: 39520180 DOI: 10.1002/ijgo.16005

Abstract

Human papillomavirus (HPV) is a sexually transmitted virus, whose persistent infection is the main reason for invasive cervical cancer (ICC), which is the fourth most common type of cancer in women, with more than 500 000 new cases every year. After infection, various alterations occur in the host, facilitating the virus's evasion of immune system clearance and promoting its proliferation. Oral probiotic consumption can influence the whole body's immunity, inflammatory reflection, neural, endocrine humoral, metabolic pathways and other organs by adjusting the components of gut microbiota (GM). Some evidence shows there is a tight connection between GM and vaginal microbiota (VM), which is referred to as the gut-vaginal axis. This review investigates the potential role of probiotics in clearing HPV via the gut-vagina axis, emphasizing the effectiveness of Lactobacillus in preventing vaginal diseases and suggesting its potential for HPV clearance. Understanding the role of probiotics in the gut-vagina axis could pave the way for new strategies to reduce and eliminate HPV and related diseases.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.